Healing From Within For Your Little One

It can be hard when your very young child has eczema. They can’t always tell you when it’s bothering them, and having it come back again and again, despite your best efforts, can be frustrating.

DUPIXENT is the only FDA-approved biologic for treating uncontrolled moderate-to-severe eczema in children ages 6 months to 5 years. It helps heal your child’s skin from within and helps you get ahead of their eczema symptoms.

DUPIXENT in combination with a topical corticosteroid was studied in a 16-week clinical trial in 162 patients ages 6 months to 5 years with moderate-to-severe eczema not adequately controlled with topical prescription treatments.

In a clinical trial at 16 weeks, children (aged 6 months to 5 years) receiving DUPIXENT* + a topical corticosteroid (TCS) saw clearer skin and less itch.


vs 4% on TCS only

Itch Relief
~5x HAD less itch

vs 9% on TCS only

Proven results ≥75%Skin Improvement in
Half of Young Children

vs 11% on TCS only

Your healthcare provider will tell you how much DUPIXENT to inject and how often.

*Children (6 months to 5 years of age) received DUPIXENT 200 mg or 300 mg every 4 weeks based
on weight, with no initial loading dose.

The most common side effects in patients with eczema include injection site reactions, eye and eyelid inflammation,
including redness, swelling, and itching, sometimes with blurred vision, cold sores in your mouth or on your lips, and high
count of a certain white blood cell (eosinophilia).

In a different type of study (open-label extension) of children (6 months - 17 years of age) continuing on DUPIXENT long-
term through 1 year, the safety results for young children (6 months-5 years) were consistent with those seen in the adult
clinical trials. In young children, hand-foot-and-mouth disease and skin papilloma (warts) were reported in the open-label
extension study. In these reported cases, patients continued treatment with DUPIXENT.

View the possible side effects of DUPIXENT in patients with moderate-to-severe eczema (atopic dermatitis).

What You Should Know About the Patients in This Study:

Had moderate-to-severe atopic dermatitis
~3.8 years
Average age
Average body surface area involvement
Had at least 1 other allergic condition

dupixent helps heal the look and feel of skin

In a clinical trial for children ages 6 months to 5 years, clearer skin was seen. Use the slider to view before and after results of an actual 4-year-old patient after 16 weeks of treatment with DUPIXENT and a topical steroid in a phase 3 clinical trial. A clinical responder was defined as a patient achieving IGA 0 or 1 (clear or almost clear skin). Individual results may vary.

Click and drag
to see results

get down to the details

Expand the boxes below to see more detailed results from the clinical study with patients ages 6 months to 5 years.

Results at 16 weeks when DUPIXENT was taken with topical corticosteroids (TCS) compared to
patients ages 6 months to 5 years on topical corticosteroids only

DUPIXENT 200 mg (11 lb to under 33 lb) or 300 mg (33 lb to under 66 lb) every 4 weeks + TCS

On TCS only

28% saw clear or almost clear skin when DUPIXENT was used with TCS vs 4% on topical corticosteroids only

53% saw at least a 75% skin improvement when DUPIXENT was used with TCS vs 11% on topical corticosteroids only

25% saw at least a 90% skin improvement when DUPIXENT was used with TCS vs 3% on topical corticosteroids only

At 16 weeks, patients ages 6 months to 5 years experienced a significant reduction in itch while participating in a clinical trial.

DUPIXENT 200 mg (11 lb to under 33 lb) or 300 mg (33 lb to under 66 lb) every 4 weeks + TCS

On TCS only

48% had significant itch reduction when DUPIXENT was used with TCS vs 9% on topical corticosteroids only

Find a Specialist Who
Treats Eczema

Use this Healthgrades™ tool to easily find nearby
specialists with experience in treating children, teens,
and adults with uncontrolled moderate-to-severe
eczema (atopic dermatitis).

Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.


Our goal is for you to get the most out of your visit to your child’s doctor so you can better understand eczema and find the right treatment option for your family. Fill out our personalized discussion guide to help yourself have a productive conversation during your next visit.


Get the Spanish caregiver discussion guide



Many parents find it helpful to use distraction techniques when giving injections to a young child. Here are a few methods you may find useful at injection time:

Infants (6-12 Months)

  • Sing a song
  • Read pop-up books

Toddlers (1-3 Years)

  • Listen to music
  • Build with blocks

Preschoolers (3-5 Years)

  • Tell a story
  • Listen to music

Find more tips like these and other resources for parents with DUPIXENT MyWay®.

Find the Answers You Need

We understand that you may have questions about DUPIXENT and how it is administered to young children. Don’t worry—we’re here to help.

Go to the How DUPIXENT Is Taken page to learn more about dosing, administration information and find more injection support resources.


Get exclusive emails, resources, and more support from DUPIXENT MyWay®.